HeartSciences Inc. HSCS
Rating
Rating Factors
Company Overview
HeartSciences Inc. is a U.S.-based medical technology company focused on applying artificial intelligence (AI) and advanced signal processing to electrocardiography (ECG) for cardiovascular screening and diagnostic support. The company operates in the digital health and medical device industries, with a primary emphasis on enhancing the clinical utility of standard ECG testing through software-driven analysis. Its core objective is to improve early detection of heart disease by identifying abnormalities that may not be visible through conventional ECG interpretation methods.
The company’s primary business activities center on AI-enabled ECG technologies, cloud-based analytics, and related cardiovascular screening solutions. HeartSciences has historically emphasized intellectual property development, algorithm design, and commercialization partnerships rather than large-scale manufacturing. The company evolved from earlier cardiovascular technology initiatives and underwent corporate transitions before adopting the HeartSciences Inc. name. Public filings and investor materials indicate that its strategy has increasingly focused on integrating AI into routine cardiovascular diagnostics for physician offices, clinics, and broader healthcare systems.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $1.63
- Current
- $4.73
- High
- $5.25
Valuation
Dividends and Shares
Corporate Info
Suite 360
Southlake, TX 76092